Apr 30, 2025 / 11:00AM GMT
Constantin Fest - GSK plc - Senior Vice President, Head-Investor Relations
Ladies and gentlemen, a very warm welcome to this GSK Q1 2025 results call. My name is Constantin Fest, new Head of IR at GSK, and I'm delighted to be joined today by Emma Walmsley, Luke Miels, and Julie Brown.
I am pleased to say Deborah Waterhouse, CEO of ViiV, returned this week full time; but David Redfern, Chairman of ViiV, will be covering HIV today. Tony Wood, our CSO, will also be joining us for Q&A.
Today's call will last approximately 1 hour with the presentation taking around 30 minutes and the remaining time for your questions. Please ask only one to two questions so that everyone has a chance to participate.
Before we start, please turn to slide 3. This is the usual Safe Harbor statement. We will comment on our performance using constant exchange rates or CER unless otherwise stated.
I will now hand over to Emma on slide 4.
Dame Emma Walmsley - GSK plc - Chief Executive Officer, Executive Director
Thank you, Constantin, and it's
Q1 2025 GSK plc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
